NanoSpy, Inc.

company

About

Rapid detection biosensor; collection to detection in 20 minutes.

  • 1 - 10

Details

Last Funding Type
Grant
Industries
Biotechnology,Food and Beverage,Food Processing
Founded date
Mar 7, 2017
Number Of Employee
1 - 10
Operating Status
Active

NanoSpy, Inc. was founded in 2017 to establish the new state-of-the-art in rapid pathogen detection. Using proprietary and patent-pending technologies, we leverage our expertise in biomedical engineering, microbiology, nanomaterials, and mechanical engineering to dramatically simplify the detection process with a new paradigm in biosensor platforms. Sensitivity, specificity, and speed now are combined in one convenient test that delivers results fast! In 20 minutes, NanoSpy biosensors can detect a single targeted pathogen at 5 CFU/mL or less from common buffer samples taken right at the point of detection.

No time-consuming enrichment process.
No environmentally hazardous reagents.
No laboratory requirements.

Translation:
No time wasted.
No decisions delayed.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$256K
NanoSpy, Inc. has raised a total of $256K in funding over 2 rounds. Their latest funding was raised on Jun 29, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 29, 2022 Grant 1 Iowa G2M Accelerator Detail
Aug 15, 2021 Grant $256K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
2
NanoSpy, Inc. is funded by 2 investors. Iowa G2M Accelerator and National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
Iowa G2M Accelerator Yes Grant
National Science Foundation Yes Grant